PointHealth
- Company typePrivate
- Founded-
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What PointHealth does
PointHealth is a San Francisco-based healthcare technology company that combines artificial intelligence with pharmacogenomics (PGx) to deliver personalized medication guidance. The company's core technology integrates patient DNA, medication history, and clinical records through proprietary AI models to generate ranked medication recommendations, drug-drug interaction flags, and gene-drug context, with the company claiming hallucination-free output and sub-10-second response times. It operates three interconnected products: PointHealth Wellness (a direct-to-consumer offering sold at $199 per at-home DNA kit via patient-app.pointhealth.ai), PointHealth Insights (a clinical decision support platform embedded in athenahealth, Epic, Cerner, and Healthie EHR workflows with provider pricing starting at $150 per kit), and PointHealth for Payers (a population health analytics solution targeting health plans on undisclosed contracts). Infrastructure is built on AWS and MongoDB (via the MongoDB for Startups program), with HIPAA-compliant data handling and CLIA-certified lab processing. The company is founder-led by Rachel Gollub (CEO, formerly CTO at Benefitter/UnitedHealth Group) and Joe Waggoner (COO, formerly Sr. Director of AI/ML Engineering at UnitedHealth Group), with Andrew Zinkel serving as Chief Medical Officer. Headcount is reported at 11-50 employees, no external funding rounds are disclosed, and the company is privately held with ownership concentrated in the founders.
PointHealth firmographics
Firmographics- Name
- PointHealth
- Legal name
- Point Health AI, Inc.
- Website
- https://pointhealth.ai
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
PointHealth industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Pharmacogenomics-Informed Medication Optimization Support (HSABALAO)
- akta.pro secondary industries
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Healthcare & Wellness Personalization (HDAAAGAI)
Keywords
Where PointHealth is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PointHealth business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- PointHealth Wellness (Patient Direct Purchase): One-time payment of $199 for a DNA cheek swab kit, lab analysis, personalized medication insights, safety review, and a clinical report for the patient's doctor. This is a direct-to-consumer B2C transaction with no subscription.
- PointHealth PGx Subscription (Provider Channel): Special pricing for providers starts at $150 per order, where providers order DNA kits directly from their EHR system and track results. The kit is introduced during patient visits and completed post-visit by the patient.
- Payer Analytics & Population Health: PointHealth helps payers reduce avoidable medication-related waste by providing patient-specific medication intelligence. Savings studies show up to $4,000/year in follow-on costs per member due to poor treatment reduction.
- athenahealth Marketplace Distribution: PointHealth's AI Treatment Decision Support app is available through the athenahealth Marketplace, generating revenue by making the solution accessible to the athenaOne network of over 160,000 providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | PointHealth Wellness - One-time patient purchase |
| Unit Pricing | Pay-as-you-go | Provider PGx Kit - Clinical pricing |
Go-to-market motion4 records
Distribution channels4 records
Marketing channels7 records
PointHealth product offering
Product offeringCore offering
PointHealth combines AI with pharmacogenomics (PGx) to deliver personalized medication guidance. The company sells a patient-facing at-home DNA kit (PointHealth Wellness, $199) and a clinical decision support product (PointHealth Insights) that integrates into provider EHRs (athenahealth, Epic, Cerner, Healthie) to surface drug-gene and drug-drug interaction alerts. It also offers PointHealth for Payers, a population health analytics solution for health plans.
Product overview
PointHealth is a precision medicine platform that combines AI and pharmacogenomics (PGx) to deliver personalized medication guidance. The platform operates as a unified system with three core products: PointHealth Wellness (for patients seeking at-home DNA testing and medication insights), PointHealth Insights (for healthcare providers with clinical decision support integrated into EHR workflows), and PointHealth for Payers (population health analytics for insurers). These products are interconnected through the PGx Vault, which stores genetic data for lifetime access across the platform, and the optional PGx Subscription add-on for providers to order DNA kits directly from their EHR. The platform's AI analyzes patient history, medications, genetics, and clinical context to generate ranked medication recommendations with safety flags, supporting over 160,000 providers through the athenahealth Marketplace integration.
Differentiator
Problem solved
Functional benefit
Brands
- PointHealth Wellness: A patient-friendly experience that explains medication insights in clear language, featuring plain-language guidance and clear medication insights.
- PointHealth Insights
Quantifiable outcome
- 30% reduction in adverse drug reactions
- +6 more outcomes
Companies that use PointHealth
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
PointHealth technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability5 records
Feature5 records
PointHealth partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, strategic and supporting.
- athenahealthcorePointHealth AI integrated its AI-powered Treatment Decision Support application into the athenaOne platform through the athenahealth Marketplace program. The integration enables prescribing clinicians to receive real-time, patient-specific treatment guidance directly within their existing clinical workflow. The partnership makes PointHealth available to more than 160,000 providers on the athenaOne network.
- Amazon Web Services (AWS)corePointHealth uses AWS infrastructure to power its AI and genomics platform. Featured in an AWS Public Sector blog alongside Protege discussing how the startups transform health treatment recommendations with AI on AWS. AWS provides the cloud infrastructure enabling PointHealth to scale precision medicine for millions.
- MongoDB (MongoDB for Startups)corePointHealth AI participates in the MongoDB for Startups program, using MongoDB infrastructure to scale precision medicine and make advanced, individualized care accessible to millions of patients. MongoDB provides the database backbone for PointHealth's AI + PGx platform.
- ProtegestrategicPointHealth and Protege partnered alongside Amazon Web Services to harness the power of genomics, advanced analytics, and AI in identifying optimal treatment for patients on the first try. Both startups presented their models at the PMWC (Precision Medicine World Conference) with AWS support.
- EpiccorePointHealth Insights is designed to integrate with Epic EHR systems, allowing providers to access patient-authorized medication intelligence directly within their Epic workflow without leaving the clinical application.
- CernercorePointHealth Insights is designed to integrate with Cerner EHR systems, allowing providers to access patient-authorized medication intelligence directly within their Cerner workflow without leaving the clinical application.
- HealthiesupportingPointHealth Insights is designed to integrate with Healthie EHR/platform, allowing providers to access patient-authorized medication intelligence within the Healthie platform, particularly relevant for behavioral health and wellness applications.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
PointHealth competitors and assessment
Company assessmentEmerging players
- Progenity: Progenity is a molecular and precision medicine company that has pursued AI-driven clinical decision support and PGx-related applications. Partial overlap with PointHealth on the genomics + clinical workflow integration thesis.
- Sema4: Sema4 (now part of GeneDx/Sema4 combined entity) is a patient-centered health intelligence company focused on genomics and AI-driven clinical insights. Comparable to PointHealth in combining AI with genomic data for clinical decision support, with stronger established health system relationships.
Direct peers
- Genomind: Genomind is a pharmacogenomics company specializing in mental health and behavioral health medication optimization. Directly comparable to PointHealth's initial behavioral health focus and PGx testing approach, with similar clinical decision support positioning for prescribers.
- Color Health: Color is a population-scale genomics and digital health company offering genetic testing, including pharmacogenomics, integrated with employer and payer programs. Directly comparable to PointHealth on the payer and DTC axes, with similar population health ambitions.
- OneOme: OneOme offers pharmacogenomic testing and clinical decision support tools for healthcare providers, including EHR integration. Directly comparable to PointHealth Insights on provider PGx workflow integration and medication decision support.
- 23andMe: 23andMe is a direct-to-consumer genetic testing company that has expanded into health-related genetic insights including medication response. Directly comparable to PointHealth Wellness on the DTC genetic testing business model and consumer pricing.
Broad incumbents
- Myriad Genetics: Myriad Genetics is an established genetic testing company offering a broad portfolio including pharmacogenomic tests (GeneSight). Overlaps with PointHealth in PGx for medication selection and has much deeper clinical evidence, reimbursement infrastructure, and sales reach.
- Tempus: Tempus is an AI-powered precision medicine company that combines clinical and molecular data to support treatment decisions. Comparable to PointHealth in the AI + genomics for treatment selection thesis, with much broader oncology and broader health system reach.
- GeneDx: GeneDx is a clinical genetic testing company with broad hereditary disease and rare disease testing capabilities. Comparable to PointHealth in DNA-based clinical decision support and EHR-integrated workflows, with significantly larger scale and provider footprint.
- Invitae: Invitae is a medical genetics company offering a broad menu of genetic tests including PGx-relevant panels. Overlaps with PointHealth on clinical-grade DNA testing infrastructure and provider channel relationships, with significantly broader test menu and market presence.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
PointHealth social profiles
Digital presencePointHealth compliance and trust
Trust signalCompliance4 records
PointHealth financial estimates
Financial estimateRevenue estimate
Valuation estimate
PointHealth leadership team
Management profileNumber of profiles
Profiles5 records
PointHealth funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PointHealth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PointHealth
What does PointHealth do?
PointHealth combines AI with pharmacogenomics (PGx) to deliver personalized medication guidance. The company sells a patient-facing at-home DNA kit (PointHealth Wellness, $199) and a clinical decision support product (PointHealth Insights) that integrates into provider EHRs (athenahealth, Epic, Cerner, Healthie) to surface drug-gene and drug-drug interaction alerts. It also offers PointHealth for Payers, a population health analytics solution for health plans.
Is PointHealth a public or private company?
PointHealth is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PointHealth founded?
PointHealth was founded in -1. It employs 11 to 50 people.
Where is PointHealth based?
PointHealth is headquartered in San Francisco, United States, in the North America region.
How does PointHealth make money?
Four revenue lines are on record. PointHealth Wellness (Patient Direct Purchase) is the primary driver. The others are pointHealth PGx Subscription (Provider Channel), payer Analytics & Population Health and athenahealth Marketplace Distribution.
Who are PointHealth's main competitors?
Emerging players on record are Progenity and Sema4. Direct peers are Genomind, Color Health, OneOme and 23andMe. Broad incumbents are Myriad Genetics, Tempus, GeneDx and Invitae.
Does PointHealth have an API?
No public API is recorded for PointHealth.
What industry is PointHealth in?
PointHealth's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HSABALAO, Pharmacogenomics-Informed Medication Optimization Support, with a secondary code of HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs). Its NAICS code is 62151 and its SIC code is 2835.